Literature DB >> 11030202

Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study.

T Hasegawa1, K Ishihara, S Takakura, H Fujii, T Nishimura, M Okazaki, N Katakami, B Umeda.   

Abstract

OBJECTIVE: To determine an appropriate duration for a short course of oral steroids in cases of asthma exacerbations.
SETTING: A 1,000 bed city hospital in Kobe, Japan. PATIENTS: Patients with asthma exacerbations who needed hospital admission.
METHODS: Following an initial treatment with a 3-day course of intravenous methylprednisolone, patients were allocated to either a 1-week (1 W) or a 2-week (2 W) course of oral prednisolone (PSL, 0.5 mg/kg). OUTCOME MEASURES: Peak expiratory flow rate (PEF) and rate of unscheduled hospital visits and readmission.
RESULTS: Twenty patients were enrolled (10 in 1 W, 10 in 2 W). Mean PEF just before starting oral PSL in 1 W and 2 W were 51 and 58% of each patient's best value. PEF was significantly improved and to a similar degree over the course of time in both 1 W and 2 W. The frequency of unexpected hospital visits during a 3-month period after discharge was similar (2 in 1 W and 2 in 2 W). No readmission occurred during the same period.
CONCLUSIONS: Because both the 1-week and the 2-week course of oral PSL were equally effective in the treatment of asthma exacerbations, 1 week may be appropriate as the maximum duration of a short rescue course of oral steroids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030202     DOI: 10.2169/internalmedicine.39.794

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

1.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

Review 2.  Asthma in adults.

Authors:  Rodolfo J Dennis; Ivan Solarte; Gustavo Rodrigo
Journal:  BMJ Clin Evid       Date:  2010-01-21

Review 3.  Asthma in adults (acute).

Authors:  Gustavo Rodrigo
Journal:  BMJ Clin Evid       Date:  2011-04-04

Review 4.  Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma.

Authors:  Serafeim Chrysovalantis Kotoulas; Ioanna Tsiouprou; Eva Fouka; Athanasia Pataka; Despoina Papakosta; Konstantinos Porpodis
Journal:  J Pers Med       Date:  2022-01-26

Review 5.  An umbrella review: corticosteroid therapy for adults with acute asthma.

Authors:  Jerry A Krishnan; Steven Q Davis; Edward T Naureckas; Peter Gibson; Brian H Rowe
Journal:  Am J Med       Date:  2009-11       Impact factor: 4.965

Review 6.  Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.

Authors:  John Blakey; Li Ping Chung; Vanessa M McDonald; Laurence Ruane; John Gornall; Chris Barton; Sinthia Bosnic-Anticevich; John Harrington; Mark Hew; Anne E Holland; Trudy Hopkins; Lata Jayaram; Helen Reddel; John W Upham; Peter G Gibson; Philip Bardin
Journal:  Respirology       Date:  2021-09-29       Impact factor: 6.175

Review 7.  Corticosteroids in the treatment of acute asthma.

Authors:  Abdullah A Alangari
Journal:  Ann Thorac Med       Date:  2014-10       Impact factor: 2.219

Review 8.  Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System.

Authors:  Cindy Strehl; Lisa Ehlers; Timo Gaber; Frank Buttgereit
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

9.  Prescription Patterns of Oral Corticosteroids for Asthma Treatment and Related Asthma Phenotypes in University Hospitals in Korea.

Authors:  Jae-Woo Kwon; Mi-Ae Kim; Da Woon Sim; Hwa Young Lee; Chin Kook Rhee; Min-Suk Yang; Ji-Su Shim; Min-Hye Kim; So Ri Kim; Chan Sun Park; Byung-Keun Kim; Sung-Yoon Kang; Gil-Soon Choi; Hyun Lee; An-Soo Jang; Sang-Heon Kim
Journal:  Allergy Asthma Immunol Res       Date:  2022-05       Impact factor: 5.096

Review 10.  Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

Authors:  Valerie Hox; Evelijn Lourijsen; Arnout Jordens; Kristian Aasbjerg; Ioana Agache; Isam Alobid; Claus Bachert; Koen Boussery; Paloma Campo; Wytske Fokkens; Peter Hellings; Claire Hopkins; Ludger Klimek; Mika Mäkelä; Ralph Mösges; Joaquim Mullol; Laura Pujols; Carmen Rondon; Michael Rudenko; Sanna Toppila-Salmi; Glenis Scadding; Sophie Scheire; Peter-Valentin Tomazic; Thibaut Van Zele; Martin Wagemann; Job F M van Boven; Philippe Gevaert
Journal:  Clin Transl Allergy       Date:  2020-01-03       Impact factor: 5.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.